ロード中...
Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Immune checkpoint inhibitors (ICIs) have shown remarkable benefit in the treatment of patients with non-small-cell lung cancer (NSCLC) and have emerged as an effective treatment option even in the first-line setting. ICIs can block inhibitory pathways that restrain the immune response against cancer...
保存先:
| 出版年: | Immune Netw |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association of Immunologists
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049584/ https://ncbi.nlm.nih.gov/pubmed/32158598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4110/in.2020.20.e10 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|